Skip to content
777 Sourcing.

Capability

Phase 2 clinical trials

Suppliers
1
States & provinces
1
Countries
1

1 phase 2 clinical trials supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

ALGOTHERAPEUTIX

SURESNES, ILE-DE-FRANCE

AlgoTherapeutix (AlgoTx) is a clinical stage biotechnology company developing targeted, first in class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a non-opioid, locally acting agent that inhibits specific nociceptive sodium channels. ATX01's lead indication is Chemotherapy-Induced Peripheral Neuropathy (CIPN), and it is in Phase 2 clinical development.

clinical stage drug development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list Phase 2 clinical trials.

Browse all capabilities